USD 53.0
(88.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.4 Million USD | 31.46% |
2022 | 1.06 Million USD | 127.71% |
2021 | 469.62 Thousand USD | 232.05% |
2020 | 141.43 Thousand USD | 367.56% |
2019 | 30.24 Thousand USD | 0.0% |
2018 | - USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 1.89 Million USD | 20.96% |
2024 Q1 | 1.56 Million USD | 11.63% |
2023 Q2 | 1.77 Million USD | 17.76% |
2023 Q3 | 1.08 Million USD | -39.07% |
2023 FY | 1.4 Million USD | 31.46% |
2023 Q1 | 1.5 Million USD | 41.1% |
2023 Q4 | 1.4 Million USD | 29.84% |
2022 Q3 | 1.06 Million USD | 57.42% |
2022 FY | 1.06 Million USD | 127.71% |
2022 Q4 | 1.06 Million USD | 0.61% |
2022 Q2 | 675.2 Thousand USD | -7.11% |
2022 Q1 | 726.87 Thousand USD | 54.78% |
2021 Q4 | 469.62 Thousand USD | 4.53% |
2021 Q1 | 326.53 Thousand USD | 130.88% |
2021 FY | 469.62 Thousand USD | 232.05% |
2021 Q2 | 107.99 Thousand USD | -66.93% |
2021 Q3 | 449.28 Thousand USD | 316.02% |
2020 FY | 141.43 Thousand USD | 367.56% |
2020 Q4 | 141.43 Thousand USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 FY | 30.24 Thousand USD | 0.0% |
2018 FY | - USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Acutus Medical, Inc. | 54.83 Million USD | 97.436% |
Biotricity, Inc. | 35.91 Million USD | 96.086% |
Cell MedX Corp. | 872.57 Thousand USD | -61.11% |
Dynatronics Corporation | 11.78 Million USD | 88.066% |
Nemaura Medical Inc. | 26.37 Million USD | 94.67% |
PetVivo Holdings, Inc. | 2.42 Million USD | 42.131% |
Sonendo, Inc. | 49.74 Million USD | 97.174% |
Telesis Bio, Inc. | 40.87 Million USD | 96.561% |
Talis Biomedical Corporation | 29.22 Million USD | 95.19% |
Viveve Medical, Inc. | 10.84 Million USD | 87.04% |